Taken together, the RNA-seq data revealed that the observed pro-differentiation effect of CP-673451 in GBM cells could be linked to the activation of KRAS- and TNFα/NF-κB-dependent signalling mechanisms. Here, NFKB1 is linked to glioblastoma.